跳转至内容
Merck
CN
  • Towards the first inhibitors of trihydroxynaphthalene reductase from Curvularia lunata: synthesis of artificial substrate, homology modelling and initial screening.

Towards the first inhibitors of trihydroxynaphthalene reductase from Curvularia lunata: synthesis of artificial substrate, homology modelling and initial screening.

Bioorganic & medicinal chemistry (2008-05-17)
Mojca Brunskole, Bogdan Stefane, Karmen Zorko, Marko Anderluh, Jure Stojan, Tea Lanisnik Rizner, Stanislav Gobec
摘要

Trihydroxynaphthalene reductase (3HNR) is an essential enzyme in the biosynthesis of fungal melanin and it represents an emerging target for the development of new fungicides and antimicotics. To promote the discovery of new inhibitors, an improved chemical synthesis of the artificial substrate 2,3-dihydro-2,5-dihydroxy-4H-benzopyran-4-one (DDBO) was developed. A series of compounds were screened on 3HNR from Curvularia lunata, a known plant pathogen and an opportunistic human pathogen, and several structurally diverse hits were obtained. Homology modelling of 3HNR from C. lunata can explain their binding modes and will enable further structure-based design of new and improved inhibitors.

材料
产品编号
品牌
产品描述

Sigma-Aldrich
布洛芬, ≥98% (GC)
Sigma-Aldrich
双氯芬酸钠 钠盐
Sigma-Aldrich
非那西丁, ≥98.0% (HPLC)
Sigma-Aldrich
1,3-茚满二酮, 97%
Sigma-Aldrich
酮洛芬, ≥98% (TLC)
Supelco
布洛芬
Sigma-Aldrich
萘普生, meets USP testing specifications
Sigma-Aldrich
布洛芬, meets USP testing specifications
Sigma-Aldrich
(S)-(+)-6-甲氧基-α-甲基-2-萘乙酸, 98%
Supelco
氧萘丙酸, VETRANAL®, analytical standard
Sigma-Aldrich
酮洛芬, meets USP testing specifications